Historical Stock Price
|
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABEO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABEO Options Chain |
| Stock Message Boards |
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on March 31, 2020, ABEO opened at $2.03, traded as high as $2.17 and as low as $1.95, and closed at $2.10. Trading volume was a total of 856.10K shares. On April 01, 2020, ABEO opened at $2.00, traded as high as $2.35 and as low as $1.90, and closed at $1.99. Trading volume was a total of 2.77M shares. On April 02, 2020, ABEO opened at $2.05, traded as high as $2.17 and as low as $1.97, and closed at $2.11. Trading volume was a total of 1.40M shares. On April 03, 2020, ABEO opened at $2.15, traded as high as $2.27 and as low as $2.06, and closed at $2.09. Trading volume was a total of 965.70K shares. On April 06, 2020, ABEO opened at $2.19, traded as high as $2.30 and as low as $2.15, and closed at $2.29. Trading volume was a total of 1.45M shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 04/06/2010 | |
| End date: | 04/06/2020 | |
| Start price/share: | $2.38 | |
| End price/share: | $2.29 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -3.78% | |
| Average Annual Total Return: | -0.38% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $9,626.13 | |
| Years: | 10.01 | |
 | |||||
| ABEO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 03/31/2020 | $2.03 | $2.17 | $1.95 | $2.10 | 856.10K |
| 04/01/2020 | $2.00 | $2.35 | $1.90 | $1.99 | 2.77M |
| 04/02/2020 | $2.05 | $2.17 | $1.97 | $2.11 | 1.40M |
| 04/03/2020 | $2.15 | $2.27 | $2.06 | $2.09 | 965.70K |
| 04/06/2020 | $2.19 | $2.30 | $2.15 | $2.29 | 1.45M |
|
| About Abeona Therapeutics |
| Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101 an AAV-based gene therapy for Sanfilippo syndrome type B. Co. is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases. |
| ABEO Historical Closing Prices | |
| Date | Close |
| 03/31/2020 | $2.10 |
| 04/01/2020 | $1.99 |
| 04/02/2020 | $2.11 |
| 04/03/2020 | $2.09 |
| 04/06/2020 | $2.29 |
| Healthcare Historical Prices |
| ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABIO Historical Stock Prices Also explore: ABEO shares outstanding history |
